An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...
Principais autores: | André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1998
|
Registros relacionados
-
Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
por: Cerundolo, V, et al.
Publicado em: (1998) -
Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
por: Kelleher, A, et al.
Publicado em: (2001) -
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
por: Gileadi, U, et al.
Publicado em: (1999) -
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
por: Klenerman, P, et al.
Publicado em: (1998) -
The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
por: Anjali K. Gupta, et al.
Publicado em: (2007-04-01)